Estrella Immunopharma, Inc.
ESLA
$0.963
-$0.0065-0.67%
NASDAQ
| 06/30/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 212.36% | -- | -56.85% | -- | -11.89% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -68.65% | -- | 51.52% | -- | -92.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 56.78% | -49.82% | -49.82% | -48.41% | -48.41% |
|
|
|||||
| Total Current Assets | 56.78% | -49.82% | -49.82% | -48.41% | -48.41% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | -- | -- | -- |
| Total Assets | 21.94% | -16.14% | -16.14% | -48.41% | -48.41% |
|
|
|||||
| Total Accounts Payable | -41.43% | -- | -- | -- | -- |
| Total Accrued Expenses | 108.92% | -- | 2,065.41% | -- | 45.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -60.00% | -- | 0.00% | -- | 0.00% |
| Total Finance Division Other Current Liabilities | 5,593.94% | -- | 6.08% | -- | 0.00% |
| Total Other Current Liabilities | 5,593.94% | -- | 6.08% | -- | 0.00% |
| Total Current Liabilities | 112.28% | 1,554.07% | 1,554.07% | 30.47% | 30.47% |
|
|
|||||
| Total Current Liabilities | 112.28% | 1,554.07% | 1,554.07% | 30.47% | 30.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 112.28% | 1,554.07% | 1,554.07% | 30.47% | 30.47% |
|
|
|||||
| Common Stock & APIC | 5.17% | -- | 0.00% | -- | 0.00% |
| Retained Earnings | -21.30% | -17.32% | -17.32% | -25.41% | -25.41% |
| Treasury Stock & Other | 0.00% | -- | -42.47% | -- | -321.40% |
| Total Common Equity | -232.88% | -82.54% | -82.54% | -49.69% | -49.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -232.88% | -82.54% | -82.54% | -49.69% | -49.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -232.88% | -- | -82.54% | -- | -49.69% |
|
|
|||||